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Two classes of inositol phosphoglycans have been implicated as
second messengers of insulin, one that activates pyruvate dehydro-
genase and contains D-chiroinositol, and one that inhibits cyclic
AMP–dependent protein kinase and contains myoinositol. We ex-
amined the effects of a 3-day fast on muscle contents of inositols
in healthy humans. An oral glucose tolerance test was performed
and a biopsy was obtained from the quadriceps femoris muscle
after an overnight fast and after a 72-hour fast. The 72-hour fast
signiﬁcantly increased plasma glucose (1.5- to 2-fold) and insulin
(2- to 4-fold) after glucose ingestion versus the values after the
overnight fast, indicating the manifestation of peripheral insulin
resistance. The 72-hour fast resulted in an »20% decrease in the
muscle content of D-chiroinositol (P<0.02), but no change in the
myoinositol content. These data demonstrate that fasting speciﬁ-
callydecreasesthemusclecontentof D-chiroinositolinhumanmus-
cle and this may contribute to the ﬁnding that insulin-mediated ac-
tivation of pyruvate dehydrogenase is attenuated after short-term
starvation.
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Larner and coworkers ﬁrst proposed the existence of a pu-
tative mediator of insulin action [1]. This idea was based on
Received 28 October 2001; accepted 21 February 2002.
This research was supported by grants from Insmed Pharmaceu-
ticals, Gamla Tj¨ anarinnor Foundation, and Karolinska Institutet. The
authors thank Drs. Barbara Hansen and Heidi Ortmeyer for useful dis-
cussions and help during the course of the study.
AddresscorrespondencetoAbramKatz,DepartmentofPhysiology
and Pharmacology, Karolinska Institutet, 171 77 Stockholm, Sweden.
E-mail: abram.katz@fyfa.ki.se
the dissociation of several actions of insulin, which suggested
that a second step after insulin binding must involve separate
pathways.Subsequently,severalinsulinmediatorswereisolated
from various mammalian tissues [2, 3]. In general, the isolated
mediators consist of inositols linked to hexosamines, hexoses,
organic phosphorus, and ethanolamine and are therefore termed
inositol phosphoglycans (IPGs) [4–6]. The isolated IPGs mimic
a number of insulin effects in vivo, on isolated cells and on
puriﬁed enzymes [7, 8]. Speciﬁcally, the IPG that contains my-
oinositol inhibits puriﬁed cyclic AMP–dependent protein ki-
nase, and the IPG that contains D-chiroinositol activates pyru-
vate dehydrogenase phosphatase (PDH phosphatase) [9]. In this
context, it is noteworthy that insulin-resistant, non–insulin de-
pendent diabetics exhibit relatively low levels of D-chiroinositol
and low bioactivity of the IPG that contains D-chiroinositol
isolated from several tissues [10, 11]. Similarly, the increase
in the bioactivity of the IPG that contains D-chiroinositol, as
well as the D-chiroinositol content of the isolated IPG from
diabetics, in response to acute increases in plasma insulin is
also smaller than corresponding values for control subjects
[11, 12].
In addition to diabetes, short-term starvation is also associ-
ated with insulin resistance in humans. Speciﬁcally, short-term
starvation results in decreased basal and insulin-mediated mus-
cle glucose uptake and carbohydrate oxidation [13–15], which
may be a consequence of diminished D-chiroinositol availabil-
ity.Thepurposeofthepresentstudy,therefore,wastodetermine
the effects of a 3-day fast on the muscle contents of inositols in
healthy humans.
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MATERIALS AND METHODS
Subjects
A total of 12 healthy volunteers participated in the study (see
Table 1). The study protocol was reviewed and approved by the
ethics committee of Karolinska Hospital and informed written
consent was given by all participants.
Protocol
Subjects reported to the laboratory after an overnight
(10-hour) fast and assumed the supine position. A local anes-
thetic(carbocain,5mg/ml)wasadministeredandanincisionwas
madeoverthelateralaspectofthequadricepsfemorismuscleof
one thigh. After »15 minutes, a biopsy was taken. Thereafter, a
plastic catheter was inserted into an antecubital vein for blood
sampling. A basal blood sample was drawn and the subjects in-
gested 75 g of glucose dissolved in 375 mL of water. Additional
blood samples were drawn at 60 and 120 minutes after glucose
ingestion. The subjects returned to the laboratory »72 hours
later and the protocol described above was repeated, with the
exception that muscle sampling was from the contralateral leg.
During the 72-hour interim, 8 subjects fasted, but were allowed
to drink water ad libitum. The remaining 4 control subjects ate
and drank normally during the interim, but also fasted overnight
prior to the second trial.
Analytical
Plasma glucose was measured with the glucose oxidase
technique using a glucose analyzer (Beckman Instruments,
Fullerton, CA, USA). Plasma insulin was measured by radioim-
munoassayandplasma¯-hyroxybutyratewithanenzymaticﬂu-
orometric technique [16].
Biopsies were quick-frozen in liquid nitrogen. Biopsies were
lyophilized, dissected free from nonmuscle constituents, pow-
dered, and thoroughly mixed, aliquoted, and stored at ¡80±C.
For analysis of glycogen, an aliquot of muscle powder was di-
gested in hot1MK O H ,neutralized, hydrolyzed enzymatically,
and analyzed for free glucose [17]. Another aliquot was homog-
TABLE 1
Subject characteristics
Group M/F Age (year) Height (cm) BMI (kg/m2) Pre-weight (kg) Post-weight (kg)
Fasted 5/3 32§2 174§3 23.5§0.4 71.1§3.4 67.9§3.2¤¤¤
Control 3/1 27§3 178§4 22.1§1.8 69.7§7.3 69.4§7.1
Note. Values are mean § SE for 8 (Fasted) and 4 (Control) subjects, respectively. Pre, after overnight fast;
Post, after 72-hour fast (Fasted group) or overnight fast on a second occasion (Control). ¤¤¤P <0.05 versus Pre.
enized,centrifuged,diluted,andanalyzedforglycogensynthase
and phosphorylase activities using ﬁlter paper techniques [18,
19] as described elsewhere [20]. Glycogen synthase fractional
activity is the activity measured in the presence of 0.17 mM
glucose-6-phosphate divided by the activity measured at satu-
rating glucose-6-phosphate (7.2 mM). Phosphorylase fractional
activity is the activity measured in the absence divided by the
activity measured in the presence of 3.3 mM AMP. Protein
was measured in the enzyme extracts with the BioRad protein
assay.
For analysis of inositols, aliquots of powder were suspended
in 6 N HCl. The tubes were sealed and heated at 100±C for
48 hours. Thereafter, the extracts were diluted in distilled wa-
ter and lyophylized. The latter step was repeated 2 more times.
Analysesofchiro-andmyoinositolswereperformedbyradioim-
munoassayusingspeciﬁcantibodiesandiodinatedtracersdevel-
oped in this laboratory (manuscript in preparation). Myoinosi-
tol was from Sigma (St. Louis, MO, USA). D-Chiroinositol was
obtained as a hydrolysis product of pinetol, originally extracted
frompinesawdust.Polyclonalantiseratochiro-andmyoinositol
weregeneratedinrabbits,usingasimmunogensthecorrespond-
ing monosuccinyl- and pentaacetylinositol, conjugated via the
succinate group directly to bovine serum albumin (Sigma RIA
grade). Similarly conﬁgured monosuccinyl- and pentaacetyli-
nositol conjugated to tyramine were used as the starting point
for chloramine T iodination and subsequent puriﬁcation of the
iodinated tracers by reverse phase C18 high-performance liquid
chromatography (HPLC). The assay required complete acetyla-
tion(hexaacetylation)ofinositolspeciesinstandardandsamples
before assay; nonacetylated inositols did not cross-react with
their respective antibodies. Complete acetylation was achieved
as follows. One hundred microliters of standard or sample (in a
1:20dilution)in1mg/mlureaand0.1%sodiumazideweredried
i na1 2£75-mm polypropylene test tube, to which were then
added100¹lofanaceticanhydride(32.5%)/pyridine(65%)/tri-
ethylamine (2.5%) mix, vortexed thoroughly, and allowed to
incubate overnight at room temperature. The next day, the in-
cubates were dried in a vacuum oven, with special care to re-
move the last traces of pyridine. For assay, 100 ¹l of sample orFASTING AND INOSITOLS IN MUSCLE 165
standard were added to 12 £ 75-mm polypropylene tubes, to-
gether with 100 ¹l of antiserum (1:1000 dilution for chiroinos-
itol antiserum; 1:2500 to myoinositol antiserum) and 100 ¹l
of iodinated tracer. After overnight incubation at room tempera-
ture,boundinositolswereprecipitatedusingpolyethyleneglycol




1 hour at room temperature. Then 1.25 ml of ice-cold 12% PEG
(average MW D 8000; Sigma) were added to each tube, which
was then vortexed and incubated an additional 1.5 hour in an ice
bath. Tubes were spun at 4000 rpm for 1 hour before pouring
off supernatant and counting pellets. Concentrations were cal-
culated off a logit-log transformation of the bound counts per
minute (cpm) data.
FIGURE 1
Plasma glucose and insulin responses to glucose ingestion. Values are mean § SE for 8 (Fasted) and 4 (Control) subjects,
respectively. Subjects were studied on the ﬁrst occasion after an overnight fast (ﬁlled circles) and on the second occasion
(unﬁlled circles) after a 72-hour fast (Fasted) or again after an overnight fast (Control). ¤P <0.05; ¤¤P <0.01; ¤¤¤P <0.001;
CP D0.07 versus ﬁrst test.
Statistics
Statistically signiﬁcant differences (P <0.05) between
means were determined with the paired t test. Values are pre-
sented as mean § SE unless otherwise indicated.
RESULTS
The 3-day fast resulted in an almost 5% decrease in body
weight (Table 1) and basal concentrations of plasma glucose
and insulin that amounted to, respectively, »70% and 50% of
the overnight fasted values (Figure 1, right panels). These re-
sults are similar to an earlier report using the same fasting pro-
tocol [13]. Additionally, the 3-day fast increased basal plasma
¯-hydroxybutyrate concentrations almost 40-fold (overnight
fast D 51§13 ¹M; 3-day fast D 1973 §345 ¹M; P <0.001).
The increases in plasma glucose and insulin after the oral166 P. N. SHASHKIN ET AL.
TABLE 2
Effects of fasting on muscle glycogen and enzyme activities
Control Fasted
Pre Post Pre Post
Glycogen 333§25 278§50 402§11 336§38
GSH 3.47§0.43 4.12§0.25 3.81§0.39 3.46§0.33¤
GSF 0.32§0.05 0.35§0.04 0.35§0.03 0.30§0.02
Phos 209§7 203§29 185§17 196§12
PF 0.19§0.02 0.20§0.03 0.21§0.04 0.22§0.02
Protein 181§6 192§21 183§14 187§12
Note. Values are mean § SE for 8 (Fasted) and 4 (Control) subjects, respectively.
Glycogen is expressed as mmol glucosyl units/kg dry muscle, whereas glycogen
synthase (C7.2 mM glucose 6-P, GSH) and phosphorylase (C3.3 mM AMP, Phos)
are expressed as mmol/min/kg dry muscle, and protein g/kg dry muscle. ¤P <0.05
versus Pre.
glucose-tolerance test after the 3-day fast were signiﬁcantly
greater than those observed after the overnight fast. In the con-
trolgroup,plasmaconcentrationsofglucoseandinsulin,aswell
as ¯-hyroxybutyrate (data not shown), were comparable on the
2 occasions, both before and after glucose ingestion (Figure 1,
left panels).
The 3-day fast decreased glycogen synthase activity
(C7.2 mM glucose-6-phosphate) in muscle by about 10%
(Table 2), which is similar to previous ﬁndings [13]. Con-
FIGURE 2
Muscle inositol contents. Values are means § S Ef o r6t o7
(Fasted) or 3 to 4 (Control) subjects. Pre and Post denote
before and after the 72-hour periods, respectively. ¤P <0.02.
comitantly, muscle glycogen content and glycogen synthase
fractional activity tended to decrease after the 3-day fast, but
the decreases did not reach statistical signiﬁcance. Neither
musclephosphorylaseactivity(C3.3mMAMP),phosphorylase
fractional activity, nor protein content was affected by the 3-day
fast. No differences in any of these variables were noted in the
control group.
The 3-day fast resulted in a signiﬁcant decrease in the mus-
cle content of D-chiroinositol (from 8.64 § 1.19 to 7.25 §
1.22pmol/mgdrymuscle),whereasthemyoinositolcontentwas
unaffected (Pre D 7.18§0.67, Post D 7.14§0.25 nmol/mg dry
muscle)(Figure2,rightpanels).Thedecreasein D-chiroinositol
averaged 16% and similar results were obtained if the values
were adjusted for protein (19% decrease, P D0.06) or phos-
phorylase (22% decrease, P <0.05). There were no signiﬁcant
differences in the inositols in the control group.
DISCUSSION
The major ﬁnding in this study is that short-term starvation
signiﬁcantly decreased the content of D-chiroinositol in human
skeletal muscle. The decrease was associated with the mani-
festation of peripheral insulin resistance, as indicated by the
exaggerated increases in plasma glucose and insulin following
glucose ingestion, as well as the decrease in glucose disposal
and carbohydrate oxidation during euglycemic hyperinsuline-
mia [13].
The present results raise the question regarding the rela-
tionship between the decreased muscle D-chiroinositol content
and insulin resistance. Published studies from several labora-
tories have already established a clear relationship between
D-chiroinositol and insulin resistance. Thus in the Rhesus mon-
key,alinearrelationshipbetweenthe24-hoururinarychiroinos-
itol excretion rate and insulin resistance was demonstrated by 5FASTING AND INOSITOLS IN MUSCLE 167
independent methods, including glucose disposal rates dur-
ingeuglycemichyperinsulinemia,serumglucosedisappearance
rates after intravenous glucose injection, and muscle and fat
biopsy determinations of glycogen synthase and phosphorylase
activity states [21]. Japanese subjects with normal glucose tol-
erance, impaired glucose tolerance, and type II diabetes were
compared with regard to 24-hour urinary chiroinositol excre-
tion and insulin sensitivity. Again, a linear relationship was
observed between 24-hour urinary chiroinositol excretion and
insulin sensitivity, with normals having the highest excretion
rates, the impaired glucose tolerance patients having decreased
excretionandthediabeticsthelowestexcretionrates[22].Previ-
ous studies have also demonstrated that non–insulin dependent
diabetes is associated with decreases in the D-chiroinositol con-
tent of IPGs isolated from skeletal muscle [11]. Concomitantly,
the bioactivity of the IPG that contains D-chiroinositol, isolated
from muscle and other body ﬂuids, is also diminished in non–
insulin dependent diabetes [10]. Moreover, the increase in the
bioactivity of the D-chiroinositol–containing IPG in response to
acuteincreasesininsulinisdiminishedinnon–insulindependent
diabetic patients, who are insulin resistant [11, 12]. Thus, the
current results that simply associate decreased D-chiroinositol
content in muscle with insulin resistance are in keeping with
a body of published data that more directly relate decreased
D-chiroinositol in urine and tissue with insulin resistance. This
relationship is further supported by the ﬁndings that administra-
tion of D-chiroinositol or pinitol (3-O-methyl-D-chironinositol)
decreases elevated blood glucose and improves insulin resis-
tance in animal models of type II diabetes [23–25] and humans
withimpairedglucosetolerance,typeIIdiabetes,andpolycystic
ovary disease [26–28]. In view of the above, the current ﬁnd-
ings could be supplemented by measurements of IPG release
following glucose ingestion, as well as assessment of urinary
inositol excretion before and after short-term starvation.
PDH is activated via dephosphorylation by PDH phos-
phatases and these phosphatases are activated in vitro by the
D-chiroinositol–containing IPG [9, 29]. Others have provided
evidence that mediators of insulin can also activate PDH in
isolated mitochondria [30, 31]. Short-term starvation decreases
the plasma insulin concentration (see above) and the activity
of the active (dephosphorylated) form of pyruvate dehydroge-
nase in insulin-sensitive tissues [32–34]. Moreover, fasting also
decreases the PDH-activating capacity of an activator isolated
from hearts [35] of insulin-treated rats. Similarly, fasting also
decreases the PDH-activating capacity of an activator isolated
from insulin-treated plasma membranes isolated from rat hepa-
tocytes [31], as well as from insulin-treated rat liver particulate
fractions [36]. The current ﬁndings provide a potential mecha-
nism for the negative effects of fasting on insulin-mediated acti-
vation of PDH, namely, that there is insufﬁcient D-chiroinositol
to generate the fully active IPG.
The mechanism for the decrease in the content of D-
chiroinositol in muscle after a 3-day fast is not known. One
possibility is that the decrease in D-chiroinositol is due to lack
ofdietaryintake.Ontheotherhand,themyoinositolcontentwas
not decreased after the 3-day fast. Alternatively, the decrease in
D-chiroinositol may be related to a decreased capacity to con-
vert myoinositol to D-chiroinositol. Myoinositol is converted to
D-chiroinositol in nonmammalian tissue by an oxidoreductive
epimerization of the C3 hydroxyl of myoinositol [37]. How-
ever, this enzymatic reaction has not been shown to produce
chiroinositol in animal tissue [38]. Nevertheless, acute insulin
administrationindiabeticsincreasesplasmaD-chiroinositolcon-
centrations by almost 10-fold and this is associated with a sig-
niﬁcant decrease in the plasma myoinositol concentration [39].
Further, administration of [3H]myoinositol to rats results in sig-
niﬁcant production of [3H]chiroinositol in insulin-sensitive tis-
sues[40],andadministrationofinsulintoratﬁbroblastsexpress-
ing the human insulin receptor results in signiﬁcant conversion
of [3H]myoinositol to [3H]chiroinositol phospholipids within
15minutes.Theseresultssupporttheideathatshort-termstarva-
tiondiminishestheconversionofmyoinositolto D-chiroinositol,
thereby explaining the decrease in D-chiroinositol content after
the 3-day fast.
In conclusion, a 3-day fast results in a decrease in D-
chiroinositol content in human skeletal muscle. This decrease
may be responsible for the attenuation of some of insulin’s
actions.
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